RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner

Mechanisms of neuroendocrine tumor (NET) proliferation are poorly understood and therapies that effectively control NET progression and metastatic disease are limited. We found amplification of a putative oncogene, RABL6A, in primary human pancreatic NETs(PNETs) that correlated with high level RABL6...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res
Egile Nagusiak: Hagen, Jussara, Muniz, Viviane P., Falls, Kelly, Reed, Sara M., Taghiyev, Agshin F., Quelle, Frederick W., Gourronc, Francoise, Klingelhutz, Aloysius J., Major, Heather J., Askeland, Ryan, Sherman, Scott K., O'Dorisio, Thomas M., Bellizzi, Andrew M., Howe, James R., Darbro, Benjamin W., Quelle, Dawn E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4233153/
https://ncbi.nlm.nih.gov/pubmed/25273089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3742
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak